Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis

被引:14
|
作者
Mikesell, Christina L. [1 ,2 ,3 ]
Kempainen, Robert R. [4 ,5 ]
Laguna, Theresa A. [2 ,3 ]
Menk, Jeremiah S. [6 ]
Wey, Andrew R. [6 ]
Gaillard, Philippe R. [7 ]
Regelmann, Warren E. [2 ,3 ]
机构
[1] Childrens Resp & Crit Care Specialists, Minneapolis, MN USA
[2] Univ Minnesota, Cyst Fibrosis Ctr, Pediat Pulmonol, Minneapolis, MN USA
[3] Masonic Childrens Hosp, Minneapolis, MN USA
[4] Hennepin Cty Med Ctr, Pulm & Crit Care Med, Minneapolis, MN USA
[5] Univ Minnesota, Cyst Fibrosis Ctr & Hosp, Minneapolis, MN USA
[6] Univ Minnesota, Clin & Translat Sci Inst, Minneapolis, MN USA
[7] Auburn Univ, Dept Math & Stat, Auburn, AL 36849 USA
关键词
adherence; cystic fibrosis; high-frequency chest wall compression; pulmonary function test; pulmonary exacerbation; PULMONARY EXACERBATIONS; MEDICATION ADHERENCE; SELF-REPORT; CHILDREN; ADULTS; ADOLESCENTS; HEALTH;
D O I
10.4187/respcare.05349
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Objective measures of adherence to high-frequency chest wall compression (HFCWC), a form of airway clearance therapy for patients with cystic fibrosis, are lacking. We used a novel electronic monitoring device integrated into an HFCWC vest to measure adherence compared with self-reported adherence. We determined factors that influenced adherence and how adherence correlated with baseline pulmonary function and pulmonary exacerbations. METHODS: Data were collected by direct measurement of date, time of day, and duration of HFCWC use to determine the number of daily treatments and daily duration of treatments. Chart review provided prescribed airway clearance therapy treatment and demographic and clinical information. Subject and caregiver report of the daily number of airway clearance therapy treatments was obtained by telephone interviews. Analysis used 2-sample and paired t test, analysis of variance, and linear regression. RESULTS: Average adherence was 69%. Adherence was highest in children (82%, P = .02) and those receiving assistance with treatment (82%, P < .001). Subjects overestimated therapy duration from a mean +/- SD of 127 +/- 169% by adults to 19.2 +/- 26.3% by parents or guardians of children. Average adherence decreased with increasing prescribed therapy time (P = .02). Average daily therapy time and adherence had significant positive associations with baseline FEV1 percent of predicted (P = .02 and P = .02, respectively) and negative associations with pulmonary exacerbations during the pre-study period and at baseline (P = .044 and P = .02, respectively). CONCLUSIONS: Greater adherence to HFCWC measured directly by a novel recorder was associated with better baseline pulmonary function and fewer exacerbations in the pre-study and baseline period. Adherence decreased with age and prescribed therapy time and increased with therapy assistance. Self-report overestimation is large and thus not an accurate measure of adherence.
引用
收藏
页码:920 / 927
页数:8
相关论文
共 50 条
  • [31] High-frequency chest wall oscillation in infective exacerbation of COPD: Is airway secretion clearance the cornerstone? Response
    Goktalay, Tugba
    CLINICAL REHABILITATION, 2014, 28 (02) : 207 - 207
  • [32] COMPARATIVE EFFICACY OF MANUAL CHEST PHYSIOTHERAPY AND A HIGH-FREQUENCY CHEST COMPRESSION VEST IN INPATIENT TREATMENT OF CYSTIC-FIBROSIS
    BURNETT, M
    TAKIS, C
    HOFFMEYER, B
    PATIL, S
    PICHURKO, B
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A30 - A30
  • [33] VENTILATORY SAVING BY HIGH-FREQUENCY CHEST WALL COMPRESSION (HFCWC)
    GEORGE, RJD
    WINTER, RJD
    FLOCKTON, SJ
    GEDDES, DM
    THORAX, 1984, 39 (03) : 235 - 235
  • [34] ADHERENCE TO AIRWAY CLEARANCE WITH HIGH FREQUENCY CHEST WALL OSCILLATION AND CHANGE IN LUNG FUNCTION THREE YEARS LATER
    Zhu, A.
    Gamble, S.
    Harris, W. T.
    Gutierrez, H.
    Oates, G. R.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 349 - 349
  • [35] Adherence to Airway Clearance Therapy in Pediatric Cystic Fibrosis: Socioeconomic Factors and Respiratory Outcomes
    Oates, Gabriela R.
    Stepanikova, Irena
    Gamble, Stephanie
    Gutierrez, Hector H.
    Harris, William T.
    PEDIATRIC PULMONOLOGY, 2015, 50 (12) : 1244 - 1252
  • [36] High-Frequency Chest-Wall Compression, Patient Safety, and the n-of-1 Construct
    Wheeler, David M.
    RESPIRATORY CARE, 2009, 54 (03) : 322 - 323
  • [37] Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis
    Barto, Tara Lynn
    Masetli, Diego Jose
    Daignault, Sarah
    Stigtich, John
    Porter, Jared
    Kraemer, Cartye
    Hansen, Gary
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [38] Immediate Effects and Safety of High-Frequency Chest Wall Compression Compared to Airway Clearance Techniques in Non-Hospitalized Infants With Acute Viral Bronchiolitis
    Gonzalez-Bellido, Vanesa
    Velaz-Baza, Veronica
    Blanco-Moncada, Elena
    Jimeno Esteo, Maria del Carmen
    Cuenca-Zaldivar, Juan Nicolas
    Colombo-Marro, Alicia
    Fagundes Donadio, Marcio Vinicius
    Torres-Castro, Rodrigo
    RESPIRATORY CARE, 2021, 66 (03) : 425 - 433
  • [39] VENTILATION BY HIGH-FREQUENCY CHEST WALL COMPRESSION IN DOGS WITH NORMAL LUNGS
    ZIDULKA, A
    GROSS, D
    MINAMI, H
    VARTIAN, V
    CHANG, HK
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (06): : 709 - 713
  • [40] HIGH-FREQUENCY CHEST-WALL COMPRESSION IN CATS WITH NORMAL LUNGS
    EYAL, FG
    HAYEK, Z
    ARMENGOL, J
    JONES, R
    PEDIATRIC RESEARCH, 1987, 21 (02) : 183 - 187